Latest Breaking News On - Moleculin biotech inc - Page 8 : vimarsana.com

Moleculin Biotech, Inc (NASDAQ:MBRX) Q4 2023 Earnings Call Transcript

Operator: Greetings, welcome to the Moleculin Biotech 2023 Year-End Conference Call and Webcast. [Operator Instructions] Please note, that this conference is being recorded.

United statesJohn paul waymackBarry whiteJonathan fosterPaul waymackWalter klempJenene thomasJonathan aschoffVernon bernardinoMoleculin biotech incMetabasis therapeutics incCollege educationExchange commissionMoleculin biotechCall transcript marchEnd conference call

Moleculin Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial

– Annamycin in combination with Cytarabine achieves CRc rate of 60% in 2nd line AML subjects – AnnAraC has potential to fill significant unmet need and expected to increase 2nd.

United statesWalter klempCytarabine annaraJenene thomasMoleculin biotech incSecurities exchangeExchange commissionPrnewswire moleculin biotech incAcute myeloid leukemiaFiscal yearChief executive officerAnnamycin responsesMoleculin biotech conferenceMoleculin biotechTranscription modulatorSecurities act

Moleculin Reports Full Year 2023 Financial Results

Moleculin Reports Full Year 2023 Financial Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoWalter klempJenene thomasExchange commissionEuropean unionAmerican society of hematology meetingSecurities exchangeMoleculin biotech incChief executive officerEuropean phaseAmerican societyHematology meetingFinancial resultsFull yearMoleculin biotech conference

StockNews com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)

StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $45.00 price target on shares of Moleculin Biotech in a research note on Thursday, December 14th. Get […]

Walterv klempMoleculin biotech incMoleculin biotech company profileSecurities exchange commissionCharles schwab investment management incRenaissance technologiesCitadel advisorsArmistice capitalAtticus wealth managementMoleculin biotechFree reportExchange commissionWealth managementSchwab investment managementGet free reportMoleculin biotech daily

Moleculin to Present at the 36th Annual ROTH Conference

Moleculin to Present at the 36th Annual ROTH Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJenene thomasJonathan fosterMoleculin biotech incPrnewswire moleculin biotech incChief financial officerMoleculin biotechTranscription modulator